Investor Relations

Corporate ProfileNuvectra™ is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other neurological indications such as sacral nerve stimulation (SNS), and deep brain stimulation (DBS). In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge, neural-interface technologies for the neuroscience pre-clinical research market.

On March 14, 2016, Nuvectra Corporation completed its spin-off from Greatbatch, Inc. into an independent, publicly-traded neurostimulation medical device company. The company is headquartered in Plano, Texas, with additional locations in Denver, Ann Arbor, and Minneapolis.

Nuvectra currently trades on the NASDAQ Global Market (NASDAQ) under the ticker symbol "NVTR."

Stock Quote NVTR (Common Stock) $12.41 - 0.48 (3.72%)
Today's Open$12.73
Previous Close$12.89
Data as of 03/23/18 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NVTR.O.  Currently trading at $12.41 with a 52 week high of $15.00 and a 52 week low of $6.15.

Recent News

March 06, 2018

Nuvectra™ Reports Fourth Quarter and Full Year 2017 Financial Results

Record Quarterly Algovita® Revenue of $10.4 Million PLANO, Texas, March 06, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced financial results for the fourth quarter and full year ended December 31, 2017. Recent Company Highlights Reported record consolidated revenues of $12.0 million for the fourth quarter 2017 and $31.8 million for the full year 2017. Achieved the 1,000th Algovita® SCS System implantation in U

Read More >

February 27, 2018

Nuvectra to Present at Two Upcoming Investor Conferences

PLANO, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at two upcoming investor conferences. Event: Cowen and Company 38th Annual Health Care Conference  Date: Monday, March 12, 2018  Time: 2:10 p.m. ET

Read More >

Investor Contact

The Ruth Group
Brian Johnston
Tram Bui

03/27/18 4:00 p.m. ET
17th Annual Needham Healthcare Conference
Location Westin Grand Central Hotel, New York